Interior Health's plans to close lab in Trail, B.C. leaves mayor and residents blindsided
The move, announced in a press release on June 13, would mean people in need of lab services such as blood tests and electrocardiograms (ECGs) will have to go to LifeLabs in Waneta Plaza, about 6 kilometres east of the Interior Health lab, which is downtown in the Trail Health Centre.
Interior Health said the lab is being closed to make the best use of staffing resources and to improve testing for patients at Trail's Kootenay Boundary Regional Hospital, which serves a large area including communities from Grand Forks to Nelson.
Since the announcement, CBC News has heard from the mayor and a handful of Trail residents who say they were shocked by the decision and that there was little consultation on the matter. The mayor is hoping that Interior Health will reconsider, or at least meet with the community to hear their concerns.
"There was no consultation, we had no idea it was happening," Mayor Colleen Jones told CBC News, adding that staff also had little notice.
Joanne Isbur, Interior Health's program director for pathology and lab medicine services, said staff will shift to the hospital to improve acute care and emergency department response. She said there are "staffing deficits" across the region, and the extra staff at the hospital will also improve services for urgent and critical patients, like cancer care and those with pre-surgical requirements.
"Interior Health recognizes that this is a significant change for patients and care providers, and employees. We've provided some time for patients to transition over to the LifeLabs location," Isbur said.
She pointed out that LifeLabs is working in partnership with the Provincial Health Services Authority and the Ministry of Health, so services offered through LifeLabs will still be covered under the Medical Services Plan.
Resident Helen Bobbitt has antiphospholipid antibody syndrome, an autoimmune condition which can cause blood clots. She relies on the clinic for regular testing and said the move is a mistake.
"I have a blood clot disorder, and if it weren't for the staff in the location of this lab, where I have to sometimes go and get last-minute lab work and have been doing so for the last 22 years, I wouldn't be able to stay on top of things," Bobbitt said.
"If they (Interior Health) can do this, with no – zero – consultation, what else can they do?"
She also voiced frustration about no longer having a lab located downtown, adding that the lab has been a staple in the community for more than 20 years.
Mayor Jones said the infrequent bus service to the Waneta Plaza will make the location more difficult for seniors and people with mobility issues to access.
On Thursday, Jones said she hopes Interior Health will reconsider the closure. She has requested a meeting with the health authority. CBC News reached out to Interior Health for comment and they said they are working on a response.
Bobbit said she's also concerned about the influx of patients at LifeLabs creating long wait-times and reducing their staffing resources. She said people from several other outlying communities, like Fruitvale, about 16 kilometres east of Trail, rely on the Interior Health lab.
"You're giving no choice but to drive everybody to one location that's only open from 7 a.m. to 3 p.m., with no transportation to rely on to get there safely," Bobbit said.
Capacity not an issue, says Interior Health
The Trail Health Centre lab saw approximately 80 to 85 patients per day over the past six months, Interior Health said, adding LifeLabs has the ability to take on these new patients.
"LifeLabs developed that location to accommodate the Trail community population. They do have the capacity to meet patient volumes," Isbur said.
In an emailed statement to CBC News, LifeLabs confirmed it is prepared to take on the large number of new patients, adding that the location in Trail has been open since 2023.
"We will be working closely with Interior Health to ensure a smooth transition for patients and health-care providers. We look forward to continuing to provide reliable, efficient, and trustworthy services for the community of Trail," the lab said in the statement.
It added that all patients who visit LifeLabs will have access to a portal that can be used to manage appointments and view results through MyCareCompass. This is separate from the MyHealthPortal with Interior Health.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
26 minutes ago
- Globe and Mail
Canada is hosting the world's biggest dementia conference for the first time in a decade. What's changed since then?
This week, researchers from around the globe are descending upon downtown Toronto to attend the Alzheimer's Association International Conference, the world's biggest and most influential meeting for dementia research. The gathering is a chance for the international dementia community to discuss the latest research in the field; it's also where significant breakthroughs are often unveiled. At a related event on Saturday, the Canadian Institutes of Health Research (CIHR) – Canada's health research funding agency – announced $44.8-million in new funding for dementia and aging-related research initiatives, including the creation of 16 teams that will study everything from Alzheimer's biomarkers to dementia in Indigenous populations. To set the stage for this year's conference, The Globe and Mail checked in with Jane Rylett, a professor at Western University and scientific director at the CIHR Institute of Aging, which hosted Saturday's event. The last time this global conference was held in Canada was in 2016, nearly a decade ago. How has the dementia research landscape changed since then? This is a really important inflection point. There is a new class of drugs, the antibody therapy, that came into the market within the last three or four years; they probably will be approved in Canada in the coming years. But while there's huge hope around it . . . right now, there's a lot of debate around if they're really beneficial. For certain people, they don't work at all; other people have negative side effects by creating inflammation in the brain. And the benefit-to-risk ratio is not great. So I think at this year's conference, it's going to be really important to hear about new findings with that. Something that's really gained momentum over the last few years is stepping back from the pharmacological approach to treatment and saying, 'What else can we do that will reduce the risk of developing dementia?' Health system urged to brace for major shift in dementia demographics The other thing that's changed is there's always been an 'amyloid hypothesis' of Alzheimer's disease, based on these toxic peptides that get made in the brain and clearly have a role in brain health and development of dementia. But during these nine years, there's been a much greater move towards understanding the role of those and recognizing that while they're still important, they're not the whole story. Now there's more openness to looking at other hypotheses about how brain health can be impacted during the life course and can lead to dementia. How should people feel about this present moment? Thinking back to 2012, the United States' health department set an ambitious goal to prevent and effectively treat Alzheimer's disease by 2025. But here we are today and that goal is far from met. When people or groups make those kinds of statements, it doesn't necessarily mesh with the complication of the thing. And then what happens is people see [the missed deadline] and think, well, it didn't happen. That's always the danger of doing something like that. The brain is a complex thing, it really is. The problem with something like Alzheimer's disease is it's so multi-faceted and it's a spectrum. There's so many areas of the brain that are impacted and the clinical presentation can look similar for people but what's happening in their brain, and where the degeneration is initiated, can be quite different. There's no one pill that you're going to have that's going to be able to change the course or alleviate the symptoms. So was it realistic to say in 2012 that this could be cured by 2025? Probably not. But it stimulated a lot of activity. We understand much more about the underlying pathology and the pathogenesis of the disease. And stepping back was an important thing, saying what can we do that is not a pharmaceutical or a pill? What are the life, behavioural and other things that we can do? Canada has a chance to change the Alzheimer's experience - let's not squander it There's been a lot of focus on the funding cuts in the U.S. that are under way right now, including to the National Institutes of Health (NIH). How has that affected things? is it looming over the conference this year? Yes. A number of Canadian researchers also have been funded by NIH, either in their own right or as subcontracts on larger studies within the U.S., and for the most part, that has been ended, which is very problematic. So we have a number of very good Canadian researchers in all fields that have lost substantial funding, and we don't have the resources in Canada to replace that. One of the big question marks is the impact it's going to have on the number of Americans that are going to be able to attend the conference. And I don't know the answer to that yet. Let's talk about Canadian researchers. What role are they playing within the broader effort? Canadian researchers are leaders internationally in these fields of study. There's really significant work being done by Canadians in the biomarkers area, so the diagnostic area. We have a lot of expertise around how to develop and promote new methods for supporting caregivers and persons with dementia. Alzheimer's trial brings at-risk patients hope for the future, but new doubts in the present We've got outstanding Indigenous cognitive health researchers that are developing new culturally safe and appropriate diagnostic and caregiving methods. And we do have some very good work going on around pathogenesis, looking at changes in the brain during aging and how that may lead to loss of cognition. That's important because you really need to understand where those earliest changes come from. Those are the targets where you need to develop drugs and therapies. This interview has been edited and condensed.
CTV News
26 minutes ago
- CTV News
Drug warning issued in North Bay area
Police in North Bay are issuing a high-priority safety alert after a recent probe of an overdose uncovered two extremely dangerous drugs. Eric Taschner has more.
CTV News
an hour ago
- CTV News
W.E. Care for Kids makes generous donation to Windsor hospital
W.E. Care for Kids donated $127,935.00 to Windsor Regional Hospital on July 22, 2025. (Source: W.E. Care for Kids) W.E. Care for Kids has donated $127,935.00 to Windsor Regional Hospital to support paediatric care for kids and their families. According to the organization, these funds will be used to purchase two Glidescope Core Intubation Systems for the paediatric operating room, along with vital equipment needed in the NICU, Family Birthing Unit and paediatric floor. 'This donation is a reflection of our ongoing mission to ensure children in Windsor-Essex receive the care they need right here at home,' said Viki Grado, executive director of W.E. Care for Kids. 'Keeping kids close to their families during medical treatment is not just about convenience – it's about giving every child the chance to heal and the best environment possible surrounded by the people who love them most.' To date, W.E. Care for Kids has raised over $10 million to improve health care services across Windsor Essex.
